Global Oligonucleotide Therapeutics Market 2020-2024
Technavio has been monitoring the oligonucleotide therapeutics market, and it is poised to grow by USD 901.18 mn during 2020-2024
, progressing at a CAGR of 10% during the forecast period. Our reports on oligonucleotide therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer and the need for personalized medicines for neurodegenerative disorders.
The oligonucleotide therapeutics market analysis includes segments as application, technology, and geographic landscape.
Technavio's oligonucleotide therapeutics market is segmented as below:
This study identifies the increased availability of approved drugs as one of the prime reasons driving the oligonucleotide therapeutics market growth during the next few years.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of critical parameters. Our oligonucleotide therapeutics market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position. In line with this, this report provides a detailed analysis of several leading oligonucleotide therapeutics market vendors that include Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Biogen Inc., Dynavax Technologies Corp., GlaxoSmithKline Plc, Ionis Pharmaceuticals Inc., Merck & Co. Inc., Miragen Therapeutics Inc., PCI Biotech Holding ASA, and Sarepta Therapeutics Inc. Also, the oligonucleotide therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of critical parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook